10 December 2013 | News | By BioSpectrum Bureau
The drugs that have been taken off the shelves include medicines to treat asthma, hypertension, ulcers and pain killers
Singapore: Taiwan's Ministry of Health and Welfare has ordered the removal of 33 drugs from shelves, as they do not conform to their own description.
Making the list of drugs public, the ministry said that the list includes products from a number of major pharmaceutical manufacturers in Taiwan, such as UC Pharma, Nang Kuang Pharmaceutical, Everest Pharm Industrial and Synmosa Biopharma Corp.
Meanwhile, the manufacturers have said that people should not be concerned about the quality of their products as the pharmaceutical ingredients were modified due to changes in regulation.
The drugs that have been taken off the shelves include 33 medicines to treat asthma, hypertension, ulcers and also includes pain killers. All are principal products for the pharmaceutical manufacturers.
Of the list of companies, Nang Kuang Pharmaceutical has the most drugs on the list (13). The companies named will now have to test each item before they can go back on the shelves, each experiment reportedly costs between $67,600 and $101,400.